BYPERSTA

Details for Australian Trade Mark No. 1226987 (hide)

Owner Amylin Pharmaceuticals, Inc. incorporated in the State

Convention US 15 November 2007 77/331011

Service Spruson & Ferguson

Various Convention priority claimed: 15 November 2007, United State of America, No. 77/331011 in respect of PHARMACEUTICAL PREPARATIONS, NAMELY PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT AND PREVENTION OF METABOLIC DISORDERS, ENDOCRINE CONDITIONS AND DI

Filing Date 27 February 2008

Classes

Class 5 Pharmaceutical preparations, including pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, diabetes, diabetic complications and hormonal diseases and disorders

Event Publications

20 March 2008 Application filed

3 April 2008 Application Accepted

31 July 2008 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1226988-STEORNLAB

1226986